← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$30K

Shares

1,500

Price

$20

Filed

Sep 25

Insider

Name

Lyssikatos Joseph P

Title

CHIEF SCIENTIFIC OFFICER

CIK

0001967150

Roles

Officer

Transaction Details

Transaction Date

2025-09-23

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

931,688

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. | The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.

Filing Info

Accession No.

0001967150-25-000004

Form Type

4

Issuer CIK

0001672619

Lyssikatos Joseph P's History

Date Ticker Type Value
2026-02-12 ELVN A $0
2026-02-12 ELVN A $0
2026-02-06 ELVN $145K
2026-01-20 ELVN $145K
2026-01-20 ELVN $390K
2026-01-09 ELVN $1.0M
2026-01-09 ELVN $1.5M
2026-01-08 ELVN $151K
2026-01-08 ELVN $842K
2025-12-19 ELVN $84K

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Kunkel Lori Anne 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$4.2M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
$296K 2026-03-06
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12